Alexandria Venture Investments, LLC — SEC insider filings

SEC reporting owner CIK 1722024. 18 insider filings on record with FilingPulse; latest filed 2026-10-15.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2020-08-25 to 2026-10-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Applied Therapeutics, Inc. (APLT)10% owner83 legs · 3,543,478 sh · $4,499,9946 legs · 875,000 sh · $2,620,92514
TRex Bio, Inc. (TRXB)10% owner21 leg · 178,571 sh · $2,499,994—3
Metacrine, Inc. (MTCR)10% owner11 leg · 38,461 sh · $499,993—4
Kymera Therapeutics, Inc. (KYMR)10% owner1——3
Silverback Therapeutics, Inc. (SBTX)10% owner1——3
Singular Genomics Systems, Inc. (OMIC)10% owner1——3
Vigil Neuroscience, Inc. (VIGL)10% owner1——3
Vor Biopharma Inc. (VOR)10% owner1——2
Xilio Therapeutics, Inc. (XLO)10% owner1——2
GreenLight Biosciences Holdings, PBC (GRNA)—1——1

Insider filings — Alexandria Venture Investments, LLC

FiledFormIssuerReported transactionsSource
2026-10-154TRex Bio, Inc. (TRXB)Conversion (C): 1,167,930 · Purchase (P): 178,571 @ $14 · Conversion (C): 1,033,541 (derivative) @ $0 · Conversion (C): 3,480,387 (derivative) @ $0EDGAR
2026-10-083TRex Bio, Inc. (TRXB)Holdings only — no transactions reportedEDGAR
2024-06-064Applied Therapeutics, Inc. (APLT)
jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC., Alexandria Equities No. 7, LLC
Sale (S): 150,000 @ $4.21 · Sale (S): 150,000 @ $4.24EDGAR
2023-12-014Applied Therapeutics Inc. (APLT)
jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC., Alexandria Equities No. 7, LLC
Other (J): 575,000 · Other (J): 575,000EDGAR
2023-11-064Applied Therapeutics Inc. (APLT)
jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC., Alexandria Equities No. 7, LLC
Sale (S): 103,808 @ $2.32 · Sale (S): 143,450 @ $2.31EDGAR
2023-11-024Applied Therapeutics Inc. (APLT)
jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC., Alexandria Equities No. 7, LLC
Sale (S): 155,000 @ $2.41 · Sale (S): 172,742 @ $2.36EDGAR
2023-10-164Applied Therapeutics Inc. (APLT)
jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC., Alexandria Equities No. 7, LLC
Other (J): 1,600,000 · Other (J): 1,600,000 · Other (J): 615,000 (derivative) · Other (J): 615,000 (derivative)EDGAR
2023-07-264GreenLight Biosciences Holdings, PBC (GRNA)
jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC.
Other (J): 1,609,909 @ $0EDGAR
2022-06-294Applied Therapeutics Inc. (APLT)
jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC., Alexandria Equities No. 7, LLC
Purchase (P): 1,435,000 @ $1 · Purchase (P): 2,065,000 @ $1 · Purchase (P): 615,000 (derivative) @ $1.00 · Purchase (P): 885,000 (derivative) @ $1.00 · Purchase (P): 2,050,000 (derivative) · Purchase (P): 2,950,000 (derivative)EDGAR
2022-02-254Applied Therapeutics Inc. (APLT)
jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC., Alexandria Equities No. 7, LLC
Other (J): 300,000 · Other (J): 300,000EDGAR
2022-01-114Vigil Neuroscience, Inc. (VIGL)Conversion (C): 192,973 · Conversion (C): 392,618 (derivative) @ $0 · Conversion (C): 142,539 (derivative) @ $0EDGAR
2021-10-264Xilio Therapeutics, Inc. (XLO)Conversion (C): 166,423 · Conversion (C): 1,581,026 (derivative)EDGAR
2021-06-014Singular Genomics Systems, Inc. (OMIC)Conversion (C): 2,645,985 @ $0 · Conversion (C): 1,796,684 (derivative) · Conversion (C): 849,301 (derivative)EDGAR
2021-02-194Applied Therapeutics Inc. (APLT)
jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC., Alexandria Equities No. 7, LLC
Purchase (P): 43,478 @ $23 · Other (J): 43,478 · Other (J): 43,478EDGAR
2021-02-094Vor Biopharma Inc. (VOR)Conversion (C): 282,804 · Conversion (C): 3,846,152 (derivative)EDGAR
2020-12-084Silverback Therapeutics, Inc. (SBTX)Conversion (C): 699,412 · Conversion (C): 1,428,570 (derivative) · Conversion (C): 1,168,347 (derivative)EDGAR
2020-09-184Metacrine, Inc. (MTCR)Conversion (C): 1,268,795 · Purchase (P): 38,461 @ $13 · Conversion (C): 4,599,997 (derivative) · Conversion (C): 1,107,899 (derivative) · Conversion (C): 762,961 (derivative)EDGAR
2020-08-254Kymera Therapeutics, Inc. (KYMR)Conversion (C): 467,932 · Conversion (C): 500,000 (derivative) · Conversion (C): 246,305 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1722024 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs